Pharmabiz

Santaana Fertility to Expand Network in partnership, investing Rs. 50 crore

Santaana Fertility is partnering with Magnet Hospitals, marking a new phase in the fertility chain’s journey. Under this ...
Pharmabiz

India's pharma, healthcare manufacturing ambitions need stronger stainless steel ecosystem, dedicated policy support: ISSDA

India's pharma, healthcare manufacturing ambitions need stronger stainless steel ecosystem, dedicated policy support: ISSDA: ...
Pharmabiz

Slow Burn Method opens registrations for the next cohort of its flagship 'Take Control' weight management programme

Slow Burn Method opens registrations for the next cohort of its flagship 'Take Control' weight management programme: Our Bureau, Mumbai Slo ...
Pharmabiz

Glenmark advances phase 3 clinical trial of trastuzumab rezetecan in platinum-resistant ovarian cancer

Glenmark advances phase 3 clinical trial of trastuzumab rezetecan in platinum-resistant ovarian cancer: Our Bureau, Mumbai Saturday, July 4, 2026, 12:15 Hrs [IST] Glenmark Special ...
Pharmabiz

Zydus signs MoU with Apollo Hospitals to expand access to the Shield Multi-Cancer Detection test in India

Zydus signs MoU with Apollo Hospitals to expand access to the Shield Multi-Cancer Detection test in India: Our Bureau, Mumbai Saturday, July 4, 2026, 11:45 Hrs [IST] Zydus Lifesci ...
Pharmabiz

Hutchmed receives China NMPA conditional approval for Orpathys to treat gastric cancer patients with MET amplification

Hutchmed receives China NMPA conditional approval for Orpathys to treat gastric cancer patients with MET amplification: Hong Kong, Shanghai Saturday, July 4, 2026, 11:00 Hrs [IST] ...
Pharmabiz

Bajaj Broking Prive Research reports tailwinds driving capex in anticipation of growth in Indian healthcare

Bajaj Broking Prive Research reports tailwinds driving capex in anticipation of growth in Indian healthcare: Our Bureau, Bengaluru Bajaj Br ...
Pharmabiz

Celea Therapeutics completes $180 million financing

PureTech Health plc, a hub-and-spoke biotherapeutics company dedicated to giving life to science and transforming innovation into value, is pleased to note that its founded entity Celea Therapeutics ...
Pharmabiz

Newron Pharmaceuticals provides update following Type A meeting with the US FDA

Newron Pharmaceuticals provides update following Type A meeting with the US FDA: Milan, Italy Saturday, July 4, 2026, 10:00 Hrs [IST] Newron Pharmaceuticals S.p.A. (Newron), a bio ...
Pharmabiz

MDC seeks further evidence to decide on exemption of antiseptic Povidone Iodine throat spray from DPCO

MDC seeks further evidence to decide on exemption of antiseptic Povidone Iodine throat spray from DPCO: Gireesh Babu, New Delhi Saturday, July 4, 2026, 08:00 Hrs [IST] The Multi-D ...
Pharmabiz

India’s eye care industry makes a strategic shift from standalone practice to institutional leadership

India’s eye care industry makes a strategic shift from standalone practice to institutional leadership: Nandita Vijayasimha, Bengaluru Saturday, July 4, 2026, 08:00 Hrs [IST] In ...
Pharmabiz

DoP amends DPCO norms related to separate ceiling prices and overcharging

DoP amends DPCO norms related to separate ceiling prices and overcharging: Gireesh Babu, New Delhi Saturday, July 4, 2026, 08:00 Hrs [IST] The Department of Pharmaceuticals (DoP) ...